Dr Waleed Shaheen Khokher, MD | |
1969 W Ogden Ave, Chicago, IL 60612-3765 | |
(312) 864-6000 | |
Not Available |
Full Name | Dr Waleed Shaheen Khokher |
---|---|
Gender | Male |
Speciality | Internal Medicine - Critical Care Medicine |
Location | 1969 W Ogden Ave, Chicago, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164040366 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 036.164245 (Illinois) | Secondary |
207RC0200X | Internal Medicine - Critical Care Medicine | 036.164245 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Waleed Shaheen Khokher, MD 1950 W Polk St Fl 8, Chicago, IL 60612-3723 Ph: (312) 864-7371 | Dr Waleed Shaheen Khokher, MD 1969 W Ogden Ave, Chicago, IL 60612-3765 Ph: (312) 864-6000 |
News Archive
Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.
News that a large and growing outbreak of highly toxic E. coli O157:H7 linked to the Gladstone Farm and Playbarn in Surrey, England has led E. coli expert Bill Marler to urge animal exhibitors on both sides of the Atlantic to implement existing safety guidelines.
According to British researchers by eating more than the recommended five portions of fruit and vegetables a day people can further reduce the risk of suffering a stroke.
Researchers at the University of Nebraska Medical Center have identified a key cell signaling pathway that drives the devastating muscle loss, or cachexia, suffered by many cancer patients.
Santaris Pharma announced today that SPC3042, a RNA-based antisense oligonucleotide developed using the company's proprietary Locked Nucleic Acid (LNA) technology, potently blocks survivin, a key survival protein in cancer cells, in both in vitro and in vivo models of prostate cancer. Importantly, SPC3042 works synergistically with the anticancer drug paclitaxel (Taxol) in both model systems.
› Verified 8 days ago
Dr. Sorin C Danciu, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3134 N Clark St, Chicago, IL 60657 Phone: 773-880-9722 | |
Anoopa A. Koshy, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 2200, Chicago, IL 60611 Phone: 312-926-6000 | |
William Edmond Gerardi, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 3730 N Lake Shore Dr, Apartment 2a, Chicago, IL 60613 Phone: 773-244-3060 | |
Suparna Dutta, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 W Van Buren St, Suite 500, Chicago, IL 60612 Phone: 312-942-4200 Fax: 312-942-3568 | |
Alexandra Dumitrescu, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Mitesh Mahesh Kabadi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 1159, Chicago, IL 60612 Phone: 312-942-5020 | |
Dr. Marta Batus, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St, Suite 809, Chicago, IL 60612 Phone: 312-563-2487 Fax: 312-942-3192 |